article thumbnail

Going green in pharmaceuticals

Drug Discovery Today

London, 25/10/2023: The pharmaceutical industry is currently responsible for over four per cent of global carbon emissions and this figure is on track to grow in the coming years. Here Simon Farnfield, event director at Lab Innovations, discusses the changes that are allowing the pharmaceutical industry to go green at last.

article thumbnail

Moderna joins the Association of the British Pharmaceutical Industry 

Drug Discovery World

Moderna has become the newest member of the UK’s pharmaceutical industry body, the Association of the British Pharmaceutical Industry (ABPI), building on the long-term commitment by the American-based company to expand its footprint and investment in the UK.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Legislative Proposals to Tackle Improper Pharmaceutical Patents in the Orange Book

Drug Patent Watch

A recent article published in Health Affairs, delves into the Federal Trade Commission’s (FTC) concerns regarding the inclusion of improper patents in the FDA’s Orange Book by pharmaceutical manufacturers.

article thumbnail

An AI Approach to Generate Novel Pharmaceuticals using Patent Data

Drug Patent Watch

A recent article published in the Journal of Cheminformatics addresses the challenge of confirming the patent status of newly developed compounds, particularly in the pharmaceutical industry, where generating novel structures… The post An AI Approach to Generate Novel Pharmaceuticals using Patent Data appeared first on DrugPatentWatch - Make Better (..)

article thumbnail

Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals

Drug Patent Watch

The article “Settled: Patent characteristics and litigation outcomes in the pharmaceutical industry,” explores the relationship between Paragraph IV litigation characteristics and the probability of a Paragraph IV settlement in the… The post Unveiling the Secrets of Patent Litigation and Settlements in Pharmaceuticals appeared first on DrugPatentWatch (..)

article thumbnail

Antimicrobial resistance with Recce Pharmaceuticals

Drug Target Review

How do Recce Pharmaceuticals’ synthetic anti-infectives differ from current therapies on the market aiming to combat the urgent global health threat posed by antimicrobial resistance (AMR)? About the author James Graham CEO of Recce Pharmaceuticals James Graham is the Chief Executive Officer of Recce Pharmaceuticals.

article thumbnail

The future of technology in pharmaceutical manufacturing

Fierce BioTech

In this interview, Charles Chase, PhD, the VP and Technical Business Development at Asymchem, a technology-focused pharmaceutical manufacturing company, discusses the significant impact of RNA vacc | Diversifying manufacturing and investing into emerging technologies improves cost effectiveness, reproducibility, and environmentally friendly processes. (..)